Pharma Pulse 9/19/24: Coverage from DPHARM 2024, What’s Ahead for Food & more

DPHARM 2024: Improving Patient Recruitment Outcomes

The first day of DPHARM in Philadelphia continued its momentum with a session on how to “Unlock the Power of the Patient for Better Patient Recruitment Outcomes,” featuring Jill Pellegrino, CEO of AutoCruitment, a company that offers direct-to-patient recruitment technology.

Study Finds Women With Asthma Are More Likely to Need Fertility Treatments

The authors also found that there was a higher frequency of miscarriages compared with women who did not have asthma.

What’s Ahead for Food

This special report explores where food is headed, from robots in restaurant kitchens to cooking oil made from algae.

Takeda Commits Over $32 Million in Five New Global Corporate Social Responsibility Partnerships to Further Drive Health Impact in 93 Countries

Takeda has committed JPY4.6 billion (Approx. USD 32 million) to five new Global Corporate Social Responsibility (CSR) partners as part of the company’s ongoing commitment to improving health systems resiliency in low and middle-income countries around the world. This commitment demonstrates Takeda’s focus on tackling systemic disparities and supporting local leadership in strengthening health infrastructure, empowering health workforce, and increasing local knowledge and capacity to improve equitable and sustainable healthcare access and delivery.

Rob Verheul on LinkedIn

Much appreciate the opportunity to contribute to the conversation around personalization in the September edition of Pharmaceutical Executive (page 6).

I'm still looking for more success (and failure) stories on personalisation - do get in touch!

#digital #pharma

Have news you want us to share in Pharma Pulse? Reach out to Social Media Editor Miranda Schmalfuhs